Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Obstructive Lung Diseases

  Free Subscription


Articles published in Curr Opin Pulm Med

Retrieve available abstracts of 50 articles:
HTML format
Text format



Single Articles


    February 2019
  1. RATHNAYAKE SNH, Van den Berge M, Faiz A
    Genetic profiling for disease stratification in chronic obstructive pulmonary disease and asthma.
    Curr Opin Pulm Med. 2019 Feb 11. doi: 10.1097/MCP.0000000000000568.
    PubMed     Text format     Abstract available


    January 2019
  2. KOCUREK EG, Jagana R
    Noncystic fibrosis bronchiectasis management: opportunities and challenges.
    Curr Opin Pulm Med. 2019 Jan 10. doi: 10.1097/MCP.0000000000000562.
    PubMed     Text format     Abstract available


    November 2018
  3. PEREZ-MIRANDA J, Traversi L, Polverino E
    Bronchiectasis in severe asthma: a distinct phenotype?
    Curr Opin Pulm Med. 2018 Nov 16. doi: 10.1097/MCP.0000000000000542.
    PubMed     Text format     Abstract available


  4. PAVORD ID
    Oral corticosteroid-dependent asthma: current knowledge and future needs.
    Curr Opin Pulm Med. 2018 Nov 16. doi: 10.1097/MCP.0000000000000541.
    PubMed     Text format     Abstract available


  5. ROMAN-RODRIGUEZ M, Metting E, Gacia-Pardo M, Kocks J, et al
    Wrong inhalation technique is associated to poor asthma clinical outcomes. Is there room for improvement?
    Curr Opin Pulm Med. 2018 Nov 15. doi: 10.1097/MCP.0000000000000540.
    PubMed     Text format     Abstract available


  6. BOULET LP, Hanania NA
    The many faces of asthma-chronic obstructive pulmonary disease overlap.
    Curr Opin Pulm Med. 2018 Nov 15. doi: 10.1097/MCP.0000000000000547.
    PubMed     Text format     Abstract available


  7. PELOZA DL, Jackson DJ
    Strategies to prevent exacerbations of childhood asthma.
    Curr Opin Pulm Med. 2018 Nov 12. doi: 10.1097/MCP.0000000000000539.
    PubMed     Text format     Abstract available


  8. ERJEFALT JS
    Unravelling the complexity of tissue inflammation in uncontrolled and severe asthma.
    Curr Opin Pulm Med. 2018 Nov 12. doi: 10.1097/MCP.0000000000000536.
    PubMed     Text format     Abstract available


  9. SEYS SF, Lokwani R, Simpson JL, Bullens DMA, et al
    New insights in neutrophilic asthma.
    Curr Opin Pulm Med. 2018 Nov 12. doi: 10.1097/MCP.0000000000000543.
    PubMed     Text format     Abstract available


  10. DIAMANT Z, Aalders W, Parulekar A, Bjermer L, et al
    Targeting lipid mediators in asthma: time for reappraisal.
    Curr Opin Pulm Med. 2018 Nov 12. doi: 10.1097/MCP.0000000000000544.
    PubMed     Text format     Abstract available


  11. ROBIJN AL, Murphy VE, Gibson PG
    Recent developments in asthma in pregnancy.
    Curr Opin Pulm Med. 2018 Nov 6. doi: 10.1097/MCP.0000000000000538.
    PubMed     Text format     Abstract available


  12. VAN DEN BERGE M, Tasena H
    Role of microRNAs and exosomes in asthma.
    Curr Opin Pulm Med. 2018 Nov 1. doi: 10.1097/MCP.0000000000000532.
    PubMed     Text format     Abstract available


  13. GRACE J, Mohan A, Lugogo NL
    Obesity and adult asthma: diagnostic and management challenges.
    Curr Opin Pulm Med. 2018 Nov 1. doi: 10.1097/MCP.0000000000000531.
    PubMed     Text format     Abstract available


    October 2018
  14. LANG JE
    Obesity and childhood asthma.
    Curr Opin Pulm Med. 2018 Oct 16. doi: 10.1097/MCP.0000000000000537.
    PubMed     Text format     Abstract available


  15. HERRERA-LUIS E, Hernandez-Pacheco N, Vijverberg SJ, Flores C, et al
    Role of genomics in asthma exacerbations.
    Curr Opin Pulm Med. 2018 Oct 16. doi: 10.1097/MCP.0000000000000533.
    PubMed     Text format     Abstract available


  16. QUIRCE S, Sastre J
    Occupational asthma: clinical phenotypes, biomarkers, and management.
    Curr Opin Pulm Med. 2018 Oct 12. doi: 10.1097/MCP.0000000000000535.
    PubMed     Text format     Abstract available


    September 2018
  17. KAVANAGH J, Jackson DJ, Kent BD
    Sleep and asthma.
    Curr Opin Pulm Med. 2018 Sep 7. doi: 10.1097/MCP.0000000000000526.
    PubMed     Text format     Abstract available


    May 2018
  18. VAN MOORSEL CHM
    Trade-offs in aging lung diseases: a review on shared but opposite genetic risk variants in idiopathic pulmonary fibrosis, lung cancer and chronic obstructive pulmonary disease.
    Curr Opin Pulm Med. 2018;24:309-317.
    PubMed     Text format     Abstract available


    March 2018
  19. HATIPOGLU U, Stoller JK
    Supplemental oxygen in patients with stable chronic obstructive pulmonary disease: evidence from Nocturnal Oxygen Treatment Trial to Long-term Oxygen Treatment Trial.
    Curr Opin Pulm Med. 2018;24:179-186.
    PubMed     Text format     Abstract available


  20. BARRECHEGUREN M, Bourbeau J
    Self-management strategies in chronic obstructive pulmonary disease: a first step toward personalized medicine.
    Curr Opin Pulm Med. 2018;24:191-198.
    PubMed     Text format     Abstract available


  21. DAS N, Topalovic M, Janssens W
    Artificial intelligence in diagnosis of obstructive lung disease: current status and future potential.
    Curr Opin Pulm Med. 2018;24:117-123.
    PubMed     Text format     Abstract available


  22. KAKKERA K, Padala KP, Kodali M, Padala PR, et al
    Association of chronic obstructive pulmonary disease with mild cognitive impairment and dementia.
    Curr Opin Pulm Med. 2018;24:173-178.
    PubMed     Text format     Abstract available


  23. IYER VN
    Low-dose oxygen therapy in COPD patients: are there any radiation-like risks?
    Curr Opin Pulm Med. 2018;24:187-190.
    PubMed     Text format     Abstract available


  24. SIDDIQUI FM, Diamond JM
    Lung transplantation for chronic obstructive pulmonary disease: past, present, and future directions.
    Curr Opin Pulm Med. 2018;24:199-204.
    PubMed     Text format     Abstract available


  25. BISWAS A, Mehta HJ, Folch EE
    Chronic obstructive pulmonary disease and lung cancer: inter-relationships.
    Curr Opin Pulm Med. 2018;24:152-160.
    PubMed     Text format     Abstract available


  26. PRESS VG, Konetzka RT, White SR
    Insights about the economic impact of chronic obstructive pulmonary disease readmissions post implementation of the hospital readmission reduction program.
    Curr Opin Pulm Med. 2018;24:138-146.
    PubMed     Text format     Abstract available


  27. SPENCER L
    Pulmonary rehabilitation for patients with acute chronic obstructive pulmonary disease exacerbations: is the evidence strengthening?
    Curr Opin Pulm Med. 2018;24:147-151.
    PubMed     Text format     Abstract available


  28. KRISHNAN JK, Martinez FJ
    Lung function trajectories and chronic obstructive pulmonary disease: current understanding and knowledge gaps.
    Curr Opin Pulm Med. 2018;24:124-129.
    PubMed     Text format     Abstract available


  29. DEAS SD, Huprikar N
    Dual bronchodilator therapy for chronic obstructive pulmonary disease: evidence for the efficacy and Safety of fixed dose combination treatments in the setting of recent guideline updates.
    Curr Opin Pulm Med. 2018;24:130-137.
    PubMed     Text format     Abstract available


    January 2018
  30. FINGLETON J, Hardy J, Beasley R
    Treatable traits of chronic airways disease.
    Curr Opin Pulm Med. 2018;24:24-31.
    PubMed     Text format     Abstract available


    December 2017
  31. CHATTERJEE K, Tarawneh AR, Alam S
    Out of proportion pulmonary hypertension in obstructive lung diseases.
    Curr Opin Pulm Med. 2017 Dec 18. doi: 10.1097/MCP.0000000000000457.
    PubMed     Text format     Abstract available


    November 2017
  32. CARPAIJ OA, van den Berge M
    The asthma-obesity relationship: underlying mechanisms and treatment implications.
    Curr Opin Pulm Med. 2017 Nov 23. doi: 10.1097/MCP.0000000000000446.
    PubMed     Text format     Abstract available


    October 2017
  33. KOCKS JWH, Seys SF, van Duin TS, Diamant Z, et al
    Assessing patient-reported outcomes in asthma and COPD patients: which can be recommended in clinical practice?
    Curr Opin Pulm Med. 2017 Oct 27. doi: 10.1097/MCP.0000000000000447.
    PubMed     Text format     Abstract available


  34. AL-SAJEE D, Oliveria JP, Sehmi R, Gauvreau GM, et al
    Antialarmins for treatment of asthma: future perspectives.
    Curr Opin Pulm Med. 2017 Oct 27. doi: 10.1097/MCP.0000000000000443.
    PubMed     Text format     Abstract available


  35. NYENHUIS SM, Apter AJ, Schatz M, Krishnan JA, et al
    Comparative effectiveness trials in asthma - how will I recognize one?
    Curr Opin Pulm Med. 2017 Oct 25. doi: 10.1097/MCP.0000000000000442.
    PubMed     Text format     Abstract available


  36. BOULET LP
    Airway remodeling in asthma: update on mechanisms and therapeutic approaches.
    Curr Opin Pulm Med. 2017 Oct 25. doi: 10.1097/MCP.0000000000000441.
    PubMed     Text format     Abstract available


  37. PITE H, Morais-Almeida M, Rocha SM
    Metabolomics in asthma: where do we stand?
    Curr Opin Pulm Med. 2017 Oct 20. doi: 10.1097/MCP.0000000000000437.
    PubMed     Text format     Abstract available


  38. HUMBERT M, Busse W, Hanania NA
    Controversies and opportunities in severe asthma.
    Curr Opin Pulm Med. 2017 Oct 20. doi: 10.1097/MCP.0000000000000438.
    PubMed     Text format     Abstract available


  39. HANANIA NA, Diamant Z
    The road to precision medicine in asthma: challenges and opportunities.
    Curr Opin Pulm Med. 2017 Oct 17. doi: 10.1097/MCP.0000000000000444.
    PubMed     Text format    


  40. BONINI M, Usmani OS
    Novel methods for device and adherence monitoring in asthma.
    Curr Opin Pulm Med. 2017 Oct 13. doi: 10.1097/MCP.0000000000000439.
    PubMed     Text format     Abstract available


  41. PARULEKAR AD, Kao CC, Diamant Z, Hanania NA, et al
    Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs.
    Curr Opin Pulm Med. 2017 Oct 13. doi: 10.1097/MCP.0000000000000436.
    PubMed     Text format     Abstract available


  42. CHUNG KF
    Precision medicine in asthma: linking phenotypes to targeted treatments.
    Curr Opin Pulm Med. 2017 Oct 13. doi: 10.1097/MCP.0000000000000434.
    PubMed     Text format     Abstract available


  43. BRAIDO F, Baiardini I, Canonica GW
    Patient-reported outcomes in asthma clinical trials.
    Curr Opin Pulm Med. 2017 Oct 13. doi: 10.1097/MCP.0000000000000440.
    PubMed     Text format     Abstract available


    March 2017
  44. ALTER A, Aboussouan LS, Mireles-Cabodevila E
    Neuromuscular weakness in chronic obstructive pulmonary disease: chest wall, diaphragm, and peripheral muscle contributions.
    Curr Opin Pulm Med. 2017;23:129-138.
    PubMed     Text format     Abstract available


  45. KWO E, Christiani D
    The role of gene-environment interplay in occupational and environmental diseases: current concepts and knowledge gaps.
    Curr Opin Pulm Med. 2017;23:173-176.
    PubMed     Text format     Abstract available


  46. HARRINGTON SE, Rogers E, Davis M
    Palliative care and chronic obstructive pulmonary disease: where the lines meet.
    Curr Opin Pulm Med. 2017;23:154-160.
    PubMed     Text format     Abstract available


  47. TSAI SC
    Chronic obstructive pulmonary disease and sleep related disorders.
    Curr Opin Pulm Med. 2017;23:124-128.
    PubMed     Text format     Abstract available


  48. RAGHAVAN D, Varkey A, Bartter T
    Chronic obstructive pulmonary disease: the impact of gender.
    Curr Opin Pulm Med. 2017;23:117-123.
    PubMed     Text format     Abstract available


  49. HANSON C, LeVan T
    Obesity and chronic obstructive pulmonary disease: recent knowledge and future directions.
    Curr Opin Pulm Med. 2017;23:149-153.
    PubMed     Text format     Abstract available


  50. SEHGAL IS, Dhooria S, Agarwal R
    Chronic obstructive pulmonary disease and malnutrition in developing countries.
    Curr Opin Pulm Med. 2017;23:139-148.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: